Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Benedikt Kaufmann, Agustina Reca, Baocai Wang, et al.
Langenbeck s Archives of Surgery (2020) Vol. 406, Iss. 1, pp. 1-17
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
Friedrich Foerster, Simon Johannes Gairing, Lukáš Müller, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 446-457
Open Access | Times Cited: 194
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
Stergios A. Pοlyzos, Lampros Chrysavgis, Ilias D. Vachliotis, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 20-35
Closed Access | Times Cited: 45
Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway
Doha Reda, Gehad E. Elshopakey, Talat A. Albukhari, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Preservation of Mitochondrial Health in Liver Ischemia/Reperfusion Injury
Ivo F. Machado, Carlos M. Palmeira, Anabela P. Rolo
Biomedicines (2023) Vol. 11, Iss. 3, pp. 948-948
Open Access | Times Cited: 18
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
Yu‐Xian Teng, Si Xie, Pingping Guo, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 955-964
Open Access | Times Cited: 25
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
Fateme Ziamanesh, Mehdi Mohammadi, Sholeh Ebrahimpour, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 1083-1094
Open Access | Times Cited: 13
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors
Wesal Elgretli, Mohamed Shengir, Shlomo Sasson, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 2
Open Access
Simulation of Image-Guided Microwave Ablation Therapy Using a Digital Twin Computational Model
Frankangel Servin, Jarrod A. Collins, Jon S. Heiselman, et al.
IEEE Open Journal of Engineering in Medicine and Biology (2023) Vol. 5, pp. 107-124
Open Access | Times Cited: 9
Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease
Jian-Kang Mu, Lei Zi, Yanqin Li, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112092-112092
Open Access | Times Cited: 19
Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management
Noha Mohamed Hany, Sanaa Eissa, Manal Basyouni, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
José Ignacio Riezu‐Boj, Miguel Barajas, Tania Pérez, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5212-5212
Open Access | Times Cited: 12
m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury
Shanshan Yu, Xiao Liu, Yan Xu, et al.
Hepatology (2023)
Closed Access | Times Cited: 7
Flavonoids from Scutellaria amoena C. H. Wright alleviate mitochondrial dysfunction and regulate oxidative stress via Keap1/Nrf2/HO-1 axis in rats with high-fat diet-induced nonalcoholic steatohepatitis
Qionglian Fang, Xue Qiao, Xunqing Yin, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114160-114160
Open Access | Times Cited: 11
Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
Ayokanmi Ore, Oluseyi Adeboye Akinloye
Medicina (2021) Vol. 57, Iss. 8, pp. 822-822
Open Access | Times Cited: 15
New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
Laia Bertran, Rosa Jorba, Andrea Barrientos‐Riosalido, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7442-7442
Open Access | Times Cited: 9
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
Ramona Cadar, Corina Lupașcu-Ursulescu, A Vasilescu, et al.
Life (2023) Vol. 13, Iss. 10, pp. 1987-1987
Open Access | Times Cited: 5
Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients
Ana Luisa Ordóñez-Vázquez, Eva Juárez-Hernández, Julia María Zuarth-Vázquez, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12221-12221
Open Access | Times Cited: 8
Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
Adnan Malik, Sadia Javaid, Muhammad Imran Malik, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 6, pp. 101544-101544
Open Access | Times Cited: 1
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
Ramona Cadar, Corina Lupașcu-Ursulescu, A Vasilescu, et al.
(2023)
Open Access | Times Cited: 3
Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review
Junxin Yan, Tongjuan Guan, Meiqi Guo, et al.
The Turkish Journal of Gastroenterology (2023) Vol. 34, Iss. 9, pp. 952-960
Open Access | Times Cited: 3
Fat Quantification Imaging and Biophysical Modeling for Patient-Specific Forecasting of Microwave Ablation Therapy
Frankangel Servin, Jarrod A. Collins, Jon S. Heiselman, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 4
Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
Shuai Wen, Ran An, Zhigang Li, et al.
Food & Nutrition Research (2022) Vol. 66
Open Access | Times Cited: 4
Development of de novo nonalcoholic fatty liver disease following pancreatectomy
Vanisha Patel, Parth Shah, Daniel Ludwig, et al.
Medicine (2023) Vol. 102, Iss. 4, pp. e32782-e32782
Open Access | Times Cited: 2
Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis
Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 198-198
Open Access
Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
Shazia Iqbal, Jihad Sebhaoui, Sajda Ashraf, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107425-107425
Closed Access
Page 1 - Next Page

Scroll to top